FDA-Inspected Site

The Procter & Gamble Co.

4 FDA inspections are on record for The Procter & Gamble Co. in Cincinnati, United States.

Clean· No action indicated

Cincinnati, United States · Last updated July 10, 2026

Overview

  • 4 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2017-06-22.

At a glance

Inspections

4

Form 483s

2

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
19 Jun 2017 – 22 Jun 2017Medical Devices & Rad HealthClean
28 May 2014 – 2 Jun 2014Medical Devices & Rad Health483On file
26 Nov 2012Not recorded483View 483 →
24 Apr 2009Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

26 Nov 2012
21 CFR 820.30(g)

Design Validation - Risk analysis not performed/inadequate

Cited by Brigitte K Hofmann

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind The Procter & Gamble Co.'s 2 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat